Scientific article
English

Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study

Published inLiver International, vol. 38, no. 3, p. 424-431
Publication date2018
Abstract

Hepatitis C virus (HCV) therapies with interferon-free second-generation direct-acting antivirals (DAAs) are highly effective and well tolerated. They have the potential to increase treatment eligibility and efficacy in HIV-infected patients. We assessed the impact of DAAs on treatment uptake and efficacy, as well as its impact on the burden of liver disease in the Swiss HIV Cohort Study (SHCS).

Research groups
Citation (ISO format)
BEGUELIN, Charles et al. Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study. In: Liver International, 2018, vol. 38, n° 3, p. 424–431. doi: 10.1111/liv.13528
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN1478-3223
459views
0downloads

Technical informations

Creation06/11/2018 16:35:00
First validation06/11/2018 16:35:00
Update time15/03/2023 16:03:42
Status update15/03/2023 16:03:42
Last indexation31/10/2024 13:04:19
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack